InsiderClue
Insiders · Profile

SCHIMMEL PAUL

Director at aTYR PHARMA · Director at ALNYLAM PHARMACEUTICALS · Director at Forte Biosciences. Filing since 30 Nov 2007. CIK 0001236447

ATYR aTYR PHARMA INC Director · 32 trades ALNY ALNYLAM PHARMACEUTICALS, INC. Director · 17 trades FBRX Forte Biosciences, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ATYR aTYR PHARMA INC
27 May 2026
Director
Bought
100,000
$49.63K
14.7%
ATYR aTYR PHARMA INC
9 Oct 2025
Director
Bought
317,999
$299.36K
29.0%
ATYR aTYR PHARMA INC
8 Oct 2025
Director
Bought
682,001
$612.44K
165%
ATYR aTYR PHARMA INC
24 Jul 2024
Director
Bought
52,300
$101.04K
14.5%
ATYR aTYR PHARMA INC
23 Jul 2024
Director
Bought
6,648
$12.07K
1.9%
ATYR aTYR PHARMA INC
22 Jul 2024
Director
Bought
41,052
$71.50K
13.1%
ATYR aTYR PHARMA INC
10 May 2023
Director
Bought
200,000
$450.00K
177%
ATYR aTYR PHARMA INC
20 Sep 2021
Director
Bought
250,000
$2.00M
×87
ATYR aTYR PHARMA INC
18 May 2021
Director
Bought
50,000
$199.00K
79.3%
ATYR aTYR PHARMA INC
20 May 2020
Director
Sold, plan not stated
8,447
$30.74K
1.9%
ATYR aTYR PHARMA INC
10 Feb 2020
Director
Bought
254,000
$1.08M
138%
ATYR aTYR PHARMA INC
26 Nov 2018
Director
Bought
147,225
$79.80K
20.0%
ATYR aTYR PHARMA INC
4 Sep 2018
Director
Bought
20,749
$15.71K
2.9%
ATYR aTYR PHARMA INC
31 Aug 2018
Director
Bought
22,000
$15.75K
3.2%
ATYR aTYR PHARMA INC
30 Aug 2018
Director
Bought
89,275
$67.48K
14.8%
ATYR aTYR PHARMA INC
29 Aug 2018
Director
Bought
75,136
$54.09K
14.2%
ATYR aTYR PHARMA INC
18 May 2018
Director
Bought
150,000
$149.45K
39.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Mar 2018
Director
Sold, plan not stated
27,823
$4.17M
100%
ATYR aTYR PHARMA INC
31 Aug 2017
Director
Bought
94,336
$249.99K
33.3%
FBRX Forte Biosciences, Inc.
19 Apr 2017
Director
Bought
10,000
$100.00K
276%
ATYR aTYR PHARMA INC
21 Dec 2016
Director
Bought
10,000
$22.82K
1.4%
ATYR aTYR PHARMA INC
20 Dec 2016
Director
Bought
15,000
$34.11K
2.2%
ATYR aTYR PHARMA INC
16 Dec 2016
Director
Bought
10,000
$23.97K
1.5%
ATYR aTYR PHARMA INC
15 Dec 2016
Director
Bought
40,000
$99.91K
6.2%
ATYR aTYR PHARMA INC
14 Apr 2016
Director
Bought
33,619
$141.86K
13.4%
ATYR aTYR PHARMA INC
14 Apr 2016
Director
Bought
32,600
$135.07K
160%
ATYR aTYR PHARMA INC
13 Apr 2016
Director
Bought
9,835
$37.86K
4.1%
ATYR aTYR PHARMA INC
12 Apr 2016
Director
Bought
6,546
$24.22K
2.8%
ATYR aTYR PHARMA INC
12 Apr 2016
Director
Bought
2,581
$9.68K
14.5%
ATYR aTYR PHARMA INC
11 Apr 2016
Director
Bought
32,659
$116.53K
17.4%
ATYR aTYR PHARMA INC
8 Apr 2016
Director
Bought
85,000
$273.65K
82.9%
ATYR aTYR PHARMA INC
7 Apr 2016
Director
Bought
40,000
$127.58K
63.9%
ATYR aTYR PHARMA INC
6 Apr 2016
Director
Bought
25,000
$80.00K
66.5%
ATYR aTYR PHARMA INC
5 Apr 2016
Director
Bought
25,000
$88.12K
199%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 Apr 2015
Director
Sold, plan not stated
10,000
$1.30M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Mar 2015
Director
Sold, plan not stated
9,053
$1.09M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Mar 2015
Director
Sold, plan not stated
947
$113.64K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
8 Dec 2014
Director
Sold, plan not stated
15,000
$1.58M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Oct 2014
Director
Sold, plan not stated
15,000
$1.43M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Jan 2014
Director
Sold, plan not stated
15,000
$1.28M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Dec 2013
Director
Sold, plan not stated
15,000
$975.00K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
22 Oct 2013
Director
Sold, plan not stated
15,000
$900.00K
10.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 Feb 2012
Director
Bought
93,023
$1,000.00K
58.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Sep 2009
Director
Sold, plan not stated
15,600
$347.29K
8.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
9 Sep 2009
Director
Sold, plan not stated
30,000
$662.93K
14.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Sep 2009
Director
Sold, plan not stated
29,400
$647.48K
12.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Dec 2007
Director
Sold, plan not stated
7,192
$229.36K
10.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
3 Dec 2007
Director
Sold, plan not stated
11,586
$377.67K
14.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 Nov 2007
Director
Sold, plan not stated
20,000
$673.96K
7.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 Nov 2007
Director
Sold, plan not stated
17,222
$569.18K
17.5%
50 decisions on file.